A research team at University College London’s Huntington’s Disease Centre investigating the first potential treatment for Huntington’s disease has announced “results of ground-breaking importance for Huntington’s disease patients and families”.
An experimental drug, known as an 'antisense oligonucleotide' (ASO), has proven to safely lower the levels of the toxic protein which causes Huntington's.
Dr Ed Wild, our scientific adviser and co-founder of Huntington's disease research website HDBuzz, answers your questions about the recent breakthrough in the Huntington's disease antisense drug trial.
Find out the latest news in the world of Huntington’s disease research by visiting HD Buzz - a website full of information about research written by scientists in plain language.
If you’ve never visited HD Buzz before take a look at this page for an overview of HD Buzz and Huntington’s disease research.
Find out about the scientific words and phrases used in Huntington’s disease research in the useful HD Buzz glossary.